VolitionRx Limited (VNRX) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 1.07M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 5.98M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 8.30M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $1.07M | $5.98M | (m) | (m) | $8.30M | (m) |
| 2026-03-31 | (m) | (m) | $940.26K | $6.35M | (m) | (m) | $9.04M | (m) |
| 2025-12-31 | (m) | (m) | $890.57K | $5.82M | (m) | (m) | $6.90M | (m) |
| 2025-09-30 | (m) | (m) | $913.58K | $5.57M | (m) | (m) | $6.45M | (m) |
| 2025-06-30 | (m) | (m) | $1.02M | $5.77M | (m) | (m) | $8.70M | (m) |
| 2025-03-31 | (m) | (m) | $862.48K | $5.53M | (m) | (m) | $8.52M | (m) |
| 2024-12-31 | (m) | (m) | $860.22K | $3.95M | (m) | (m) | $9.40M | (m) |
| 2024-09-30 | (m) | (m) | $965.02K | $3.84M | (m) | (m) | $12.68M | (m) |
| 2024-06-30 | (m) | (m) | $1.04M | $3.87M | (m) | (m) | $13.07M | (m) |
| 2024-03-31 | (m) | (m) | $1.15M | $3.37M | (m) | (m) | $19.43M | (m) |
| 2023-12-31 | (m) | (m) | $1.21M | $3.62M | (m) | (m) | $27.95M | (m) |
| 2023-09-30 | (m) | (m) | $1.26M | $2.09M | (m) | (m) | $18.04M | (m) |
| 2023-06-30 | (m) | (m) | $1.20M | $2.45M | (m) | (m) | $27.56M | (m) |
| 2023-03-31 | (m) | (m) | $1.12M | $2.55M | (m) | (m) | $18.04M | (m) |
| 2022-12-31 | (m) | (m) | $1.07M | $2.78M | (m) | (m) | $18.30M | (m) |
| 2022-09-30 | (m) | (m) | $1.06M | $2.28M | (m) | (m) | $23.34M | (m) |
| 2022-06-30 | (m) | (m) | $1.09M | $1.74M | (m) | (m) | $24.35M | (m) |
| 2022-03-31 | (m) | (m) | $1.33M | $2.03M | (m) | (m) | $31.68M | (m) |
| 2021-12-31 | (m) | (m) | $797.86K | $2.27M | (m) | (m) | $27.49M | (m) |
| 2021-09-30 | (m) | (m) | $759.51K | $2.03M | (m) | (m) | $30.00M | (m) |
| 2021-06-30 | (m) | (m) | $822.37K | $2.22M | (m) | (m) | $35.24M | (m) |
| 2021-03-31 | (m) | (m) | $840.56K | $2.39M | (m) | (m) | $40.51M | (m) |
| 2020-12-31 | (m) | (m) | $841.32K | $2.61M | (m) | (m) | $26.15M | (m) |
| 2020-09-30 | (m) | (m) | $765.15K | $1.83M | (m) | (m) | $26.09M | (m) |
| 2020-06-30 | (m) | (m) | $692.72K | $1.91M | (m) | (m) | $26.25M | (m) |
| 2020-03-31 | (m) | (m) | $612.65K | $2.06M | (m) | (m) | $16.87M | (m) |
| 2019-12-31 | (m) | (m) | $647.57K | $2.20M | (m) | (m) | $21.29M | (m) |
| 2019-09-30 | (m) | (m) | (m) | $1.73M | (m) | (m) | $23.78M | (m) |
| 2019-06-30 | (m) | (m) | $562.75K | $1.96M | (m) | (m) | $22.88M | (m) |
| 2019-03-31 | (m) | (m) | (m) | $1.80M | (m) | (m) | $20.63M | (m) |
| 2018-12-31 | (m) | (m) | (m) | $1.98M | (m) | (m) | $17.49M | (m) |
| 2018-09-30 | (m) | (m) | (m) | $1.87M | (m) | (m) | $20.72M | (m) |
| 2018-06-30 | (m) | (m) | (m) | $1.98M | (m) | (m) | $16.30M | (m) |
| 2018-03-31 | (m) | (m) | (m) | $1.30M | (m) | (m) | $18.98M | (m) |
| 2017-12-31 | (m) | (m) | (m) | $1.31M | (m) | (m) | $14.62M | (m) |
| 2017-09-30 | (m) | (m) | (m) | $1.05M | (m) | (m) | $18.36M | (m) |
| 2017-06-30 | (m) | (m) | (m) | $1.06M | (m) | (m) | $20.97M | (m) |
| 2017-03-31 | (m) | (m) | (m) | $691.89K | (m) | (m) | $22.53M | (m) |
| 2016-12-31 | (m) | (m) | (m) | $432.03K | (m) | (m) | $24.73M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |